Loading institutional data...
Loading institutional data...
Held by 1,380 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $1825.21 today, the market must believe free cash flow compounds 1.9%/yr for a decade (off $7.5B normalized FCF).
The market's 1.9% is more conservative than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt $5.5B
mean 114.8% · volatility σ 175% · implied rate exceeded in 7/9 yrs
Central path = implied 1.9%/yr growth; shaded band = ±1σ (175%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 490 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMZN | $2.70T | — | — | — | — | — | — | 20.5% | 16.2% | — | 5,764 |
| TSLA | $1.37T | 339.1× | 145.5× | 14.5× | -2.9% | 18.0% | 4.0% | 4.6% | 4.2% | 0.9× | 4,029 |
| TM | $614.2B | 60.0× | 24.8× | 2.6× | 3.8% | 18.4% | 4.4% | 7.9% | 5.9% | 1.7× | 665 |
| PDD | $442.6B | 32.9× | 31.9× | 7.2× | 14.5% | 56.3% | 22.7% | 23.7% | 23.7% | — | 548 |
| HD | $301.3B | 21.3× | 14.3× | 1.8× | 3.2% | 33.3% | 8.6% | 110% | 22.8% | 2.0× | 3,970 |
| BABA | $201.7B | 135.7× | — | 1.4× | 8.1% | 39.8% | 10.1% | 9.8% | 9.8% | — | 1,298 |
| TJX | $140.1B | 26.0× | — | 2.3× | 7.1% | 31.0% | 9.1% | 53.9% | 42.1% | — | 2,608 |
| HTHT | $132.7B | 187.9× | 114.3× | — | — | — | — | 39.7% | 27.3% | 0.7× | 258 |
| SBUX | $109.9B | 59.3× | 26.8× | 3.0× | 2.8% | — | 5.0% | -22.9% | 23.3% | 3.4× | 2,252 |
| LOW | $108.9B | 16.4× | 12.0× | 1.3× | 3.1% | 33.5% | 7.7% | -67.1% | 22.3% | 3.2× | 2,591 |
| ABNB | $101.7B | — | 37.9× | 8.3× | 10.3% | 83.0% | 20.5% | 30.6% | 24.6% | 0.8× | 1,246 |
| MELI | $92.5B | 46.3× | — | 3.2× | 39.1% | 44.5% | 6.9% | 29.6% | 12.5% | — | 1,380 |
| MAR | $88.8B | 35.1× | 20.6× | 3.4× | 4.3% | — | 9.9% | -69.0% | -69.4% | 0.0× | 1,559 |
| LKNCY | $86.3B | 168.2× | 90.8× | 12.3× | 48.9% | — | 7.3% | 23.0% | 23.0% | — | 9 |
| GM | $78.3B | 26.5× | 3.9× | 0.4× | -1.3% | — | 1.5% | 4.4% | 4.4% | — | 1,447 |
| ROST | $74.0B | 34.7× | 22.0× | 3.3× | 7.7% | 27.7% | 9.4% | 34.7% | 27.8% | 0.5× | 1,276 |
| ORLY | $71.5B | 28.6× | 19.5× | 4.0× | 6.4% | 51.6% | 14.3% | -333% | 48.3% | 1.5× | 1,569 |
| HLT | $69.7B | 49.4× | 24.0× | 5.8× | 7.7% | — | 12.1% | -27.0% | -27.0% | — | 1,126 |
| RCL | $67.7B | 16.0× | — | 3.8× | 8.8% | 49.4% | 23.8% | 42.5% | 32.3% | — | 1,114 |
| SE | $62.0B | 40.2× | 24.6× | 2.7× | 36.4% | 44.7% | 6.9% | 12.6% | 12.6% | — | 718 |
| F | $54.2B | — | 4.5× | 0.3× | 1.2% | 6.8% | -4.4% | -22.7% | -22.7% | — | — |
| NKE | $53.9B | 17.3× | — | 1.2× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | — | 1,848 |
| EBAY | $50.7B | 26.0× | 18.4× | 4.6× | 7.9% | 71.5% | 18.3% | 45.3% | 38.8% | 0.3× | 1,182 |
| AZO | $47.8B | 19.6× | 13.3× | 2.5× | 2.4% | 52.6% | 13.2% | -73.2% | 46.4% | 2.1× | 1,245 |
| CMG | $44.8B | 29.4× | 19.4× | 3.8× | 5.4% | — | 12.9% | 54.3% | 54.3% | 0.0× | 1,203 |
Peers = companies sharing MELI's sector (Consumer Cyclical) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.89B 100.0% | $20.78B 100.0% | $15.11B 100.0% | $10.78B 100.0% | $7.07B 100.0% | $3.97B 100.0% | $2.30B 100.0% | $1.44B 100.0% | $1.22B 100.0% | $844.4M 100.0% |
| Cost of Revenue | $16.04B 55.5% | $11.20B 53.9% | $7.52B 49.8% | $5.58B 51.8% | $4.06B 57.5% | $2.27B 57.0% | $1.19B 52.0% | $742.6M 51.6% | $496.9M 40.8% | $307.5M 36.4% |
| Gross Profit | $12.86B 44.5% | $9.58B 46.1% | $7.59B 50.2% | $5.20B 48.2% | $3.00B 42.5% | $1.71B 43.0% | $1.10B 48.0% | $697.0M 48.4% | $719.6M 59.2% | $536.9M 63.6% |
| Research & Development | $2.27B 7.9% | $1.93B 9.3% | $1.83B 12.1% | $1.10B 10.2% | $590.0M 8.3% | $353.0M 8.9% | $223.8M 9.7% | $146.3M 10.2% | $127.2M 10.5% | $98.5M 11.7% |
| Selling, General & Admin | $1.08B 3.7% | $963.0M 4.6% | $766.0M 5.1% | $661.0M 6.1% | $465.0M 6.6% | $327.0M 8.2% | $197.5M 8.6% | $137.8M 9.6% | $122.2M 10.0% | $87.3M 10.3% |
| Total Operating Expenses | $9.66B 33.4% | $6.95B 33.4% | $5.38B 35.6% | $4.13B 38.3% | $2.56B 36.3% | $1.58B 39.8% | $1.26B 54.7% | $766.5M 53.2% | $663.3M 54.5% | $355.8M 42.1% |
| Operating Income | $3.20B 11.1% | $2.63B 12.7% | $2.21B 14.6% | $1.07B 9.9% | $441.0M 6.2% | $128.0M 3.2% | -$153.2M -6.7% | -$69.5M -4.8% | $56.3M 4.6% | $181.1M 21.4% |
| Interest Expense | — | — | — | — | — | — | — | — | $18.5M 1.5% | $17.9M 2.1% |
| Interest & Investment Income | $138.0M 0.5% | $148.0M 0.7% | $135.0M 0.9% | $44.0M 0.4% | $138.0M 2.0% | $103.0M 2.6% | $113.5M 4.9% | $42.0M 2.9% | $45.9M 3.8% | $35.4M 4.2% |
| Pretax Income | $2.84B 9.8% | $2.43B 11.7% | $1.55B 10.3% | $780.0M 7.2% | $241.0M 3.4% | $81.0M 2.0% | -$107.2M -4.7% | -$65.5M -4.5% | $54.1M 4.4% | $185.3M 21.9% |
| Income Tax Expense | $845.0M 2.9% | $521.0M 2.5% | $569.0M 3.8% | $298.0M 2.8% | $149.0M 2.1% | $82.0M 2.1% | $64.8M 2.8% | -$28.9M -2.0% | $40.3M 3.3% | $49.0M 5.8% |
| Net Income | $2.00B 6.9% | $1.91B 9.2% | $987.0M 6.5% | $482.0M 4.5% | $83.0M 1.2% | -$1.0M -0.0% | -$172.0M -7.5% | -$36.6M -2.5% | $13.8M 1.1% | $136.4M 16.1% |
| Per Share | ||||||||||
| EPS (Basic) | $39.40 | $37.69 | $19.64 | $9.57 | $1.67 | $-0.08 | $-3.71 | $-0.82 | $0.31 | $3.09 |
| EPS (Diluted) | $39.40 | $37.69 | $19.46 | $9.53 | $1.67 | $-0.08 | $-3.71 | $-0.82 | $0.31 | $3.09 |
| Weighted Avg Shares (Basic) | 50.7M | 50.7M | 50.3M | 50.3M | 49.8M | 49.7M | 48.7M | 44.5M | 44.2M | 44.2M |
| Weighted Avg Shares (Diluted) | 50.7M | 50.7M | 51.0M | 51.3M | 49.8M | 49.7M | 48.7M | 44.5M | 44.2M | 44.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $1M buybacks = $1M returned on $10.8B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Interest last disclosed in FY2017 (no longer broken out).
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 14th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 51.6 | 52.0 | 57.0 | 57.5 | 51.8 | 49.8 | 53.9 | 55.5 |
| Gross Profit | 48.4 | 48.0 | 43.0 | 42.5 | 48.2 | 50.2 | 46.1 | 44.5 |
| R&D | 10.2 | 9.7 | 8.9 | 8.3 | 10.2 | 12.1 | 9.3 | 7.9 |
| SG&A | 9.6 | 8.6 | 8.2 | 6.6 | 6.1 | 5.1 | 4.6 | 3.7 |
| Operating Income | -4.8 | -6.7 | 3.2 | 6.2 | 9.9 | 14.6 | 12.7 | 11.1 |
| Income Tax | -2.0 | 2.8 | 2.1 | 2.1 | 2.8 | 3.8 | 2.5 | 2.9 |
| Net Income | -2.5 | -7.5 | -0.0 | 1.2 | 4.5 | 6.5 | 9.2 | 6.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MELI: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.